Q3 2019 Holdings
Filed 2019-11-14 | 59 holdings | $103.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $47.4M | 4,165,558 | 45.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $32.6M | 3,579,023 | 31.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $13.9M | 1,877,148 | 13.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $9.2M | 3,047,155 | 8.8% |
| Merus N V | COM | N5749R100 | $82.7K | 4,639,413 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $61.7K | 2,844,145 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $56.0K | 935,548 | 0.1% |
| AC Immune SA(ACIU) | SHS | H00263105 | $55.9K | 11,297,911 | 0.1% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $46.6K | 305,076 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $35.1K | 1,796,942 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $32.1K | 437,565 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $31.7K | 7,361,801 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $30.3K | 1,998,276 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $24.3K | 1,749,709 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $24.1K | 710,697 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $24.1K | 308,984 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $22.3K | 3,380,604 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $20.9K | 6,750,482 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $18.2K | 5,349,905 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $18.0K | 17,426,968 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $17.6K | 1,223,925 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.7K | 1,741,600 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $15.1K | 2,108,662 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $14.6K | 3,765,168 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $13.2K | 1,764,784 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $13.0K | 1,441,429 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $12.4K | 353,818 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.7K | 471,746 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $10.0K | 939,704 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $9.6K | 1,414,515 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $8.9K | 2,640,565 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $8.8K | 1,832,484 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.2K | 682,630 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $8.1K | 656,483 | 0.0% |
| Verastem Inc | COM | 92337C104 | $7.7K | 6,328,994 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $7.5K | 593,474 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $7.5K | 2,321,236 | 0.0% |
| Forward Pharma A/S | SPONSORED ADS | 34986J105 | $6.6K | 6,480,079 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $6.4K | 4,041,888 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $6.1K | 2,100,305 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $5.8K | 6,929,690 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $5.5K | 539,512 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $5.4K | 2,687,738 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $4.8K | 1,378,841 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $4.6K | 1,733,036 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM | 867328700 | $4.5K | 6,194,925 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.5K | 1,137,764 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $4.3K | 1,000,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $3.7K | 2,221,272 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.1K | 344,196 | 0.0% |